Cytokinetics
CYTK
#1824
Rank
A$16.93 B
Marketcap
A$124.76
Share price
1.44%
Change (1 day)
145.03%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2026 (TTM): -A$1.24 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$0.10 Billion. In 2025 the company made an earning of -A$1.14 Billion a decrease over its 2024 earnings that were of -A$0.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.24 Billion9.37%
2025 -A$1.14 Billion33.15%
2024 -A$0.86 Billion12.03%
2023 -A$0.76 Billion35.3%
2022 -A$0.57 Billion80.65%
2021 -A$0.32 Billion69.15%
2020 -A$0.19 Billion4.6%
2019 -A$0.18 Billion14.49%
2018 -A$0.16 Billion-16.83%
2017 -A$0.19 Billion-812.8%
2016 A$25.86 M-147.81%
2015 -A$54.1 Million156.05%
2014 -A$21.13 Million-56.56%
2013 -A$48.64 Million-16.48%
2012 -A$58.24 Million-15.65%
2011 -A$69.04 Million-3.24%
2010 -A$71.36 Million-308.68%
2009 A$34.19 M-141.87%
2008 -A$81.66 Million0.21%
2007 -A$81.49 Million-7.91%
2006 -A$88.49 Million37.42%
2005 -A$64.39 Million16.13%
2004 -A$55.45 Million-19.29%
2003 -A$68.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$13.10 B-1,195.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$44.8 Million-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.23 B-119.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.4 Billion-67.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$2.73 Million-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA